Cui, Z., Rodday, A. M., Tighiouart, H., Counsell, N., Rossetti, S., Upshaw, J., Kirkwood, A., Li, H., Advani, R., Casasnovas, O., Cerhan, J., Federico, M., Gallamini, A., Ghesquieres, H., Hawkes, E., Hodgson, D., Hutchings, M., Johnson, P., Link, B., Mou, E., Radford, J., Savage, K., Stephens, D., Zinzani, P. L., Maurer, M., Rossi, C., Evens, A., Parsons, S. (2025). PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course. Blood. https://doi.org/10.1182/blood-2025-129